209 related articles for article (PubMed ID: 30531243)
1. Gastric Neuroendocrine Tumor and Duodenal Gastrinoma With Chronic Autoimmune Atrophic Gastritis.
Chen WC; Warner RRP; Harpaz N; Zhu H; Roayaie S; Kim MK
Pancreas; 2019 Jan; 48(1):131-134. PubMed ID: 30531243
[TBL] [Abstract][Full Text] [Related]
2. Novel association of duodenal gastrinoma and atrophic gastritis: case report and literature review.
Lendel I; Manni A; Ruggiero FM
Endocr Pract; 2007; 13(7):770-5. PubMed ID: 18194935
[TBL] [Abstract][Full Text] [Related]
3. The various faces of autoimmune endocrinopathies: non-tumoral hypergastrinemia in a patient with lymphocytic colitis and chronic autoimmune gastritis.
Melcescu E; Hogan RB; Brown K; Boyd SA; Abell TL; Koch CA
Exp Mol Pathol; 2012 Dec; 93(3):434-40. PubMed ID: 23043903
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis and treatment of gastric neuroendocrine tumours.
Plöckinger U
Wien Klin Wochenschr; 2007; 119(19-20):570-2. PubMed ID: 17985089
[TBL] [Abstract][Full Text] [Related]
5. Hypergastrinemia--diagnosis and treatment.
Niederle B
Wien Klin Wochenschr; 2007; 119(19-20):561-3. PubMed ID: 17985087
[No Abstract] [Full Text] [Related]
6. [Metastatic duodenal gastrinoma and autoimmune atrophic chronic gastritis].
Maunoury V; Huglo D; Leteurtre E; Etmedkjdian S; Oudar C; Meurisse F; Proye C
Gastroenterol Clin Biol; 2003 Nov; 27(11):1042-3. PubMed ID: 14732854
[No Abstract] [Full Text] [Related]
7. Diagnosis and differential diagnosis of hypergastrinemia.
Arnold R
Wien Klin Wochenschr; 2007; 119(19-20):564-9. PubMed ID: 17985088
[TBL] [Abstract][Full Text] [Related]
8. Management of gastric and duodenal neuroendocrine tumors.
Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
[TBL] [Abstract][Full Text] [Related]
9. [Gastric neuroendocrine tumor with hypergastrinemia following type B chronic atrophic gastritis: a case report].
Yamaguchi E; Iwasa T; Ihara E; Tomita Y; Aso A; Oki E; Nakano K; Hirahashi M; Nakamura K
Nihon Shokakibyo Gakkai Zasshi; 2017; 114(2):248-255. PubMed ID: 28163290
[TBL] [Abstract][Full Text] [Related]
10. Case of a tumor comprising gastric cancer and duodenal neuroendocrine tumor.
Kaneko H; Miyake A; Ishii Y; Sue S; Miwa H; Sasaki T; Tamura T; Kondo M; Maeda S
World J Gastroenterol; 2016 Sep; 22(36):8242-6. PubMed ID: 27688667
[TBL] [Abstract][Full Text] [Related]
11. Duodenal gastrinoma with multiple gastric neuroendocrine tumors secondary to chronic Helicobacter pylori gastritis.
Grin A; Kim YI; Mustard R; Streutker CJ; Riddell RH
Am J Surg Pathol; 2012 Jun; 36(6):935-40. PubMed ID: 22588069
[TBL] [Abstract][Full Text] [Related]
12. Malignant transformation of a gastric hyperplastic polyp in a context of Helicobacter pylori-negative autoimmune gastritis: a case report.
Yamanaka K; Miyatani H; Yoshida Y; Ishii T; Asabe S; Takada O; Nokubi M; Mashima H
BMC Gastroenterol; 2016 Oct; 16(1):130. PubMed ID: 27729029
[TBL] [Abstract][Full Text] [Related]
13. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
14. Netazepide, a gastrin/cholecystokinin-2 receptor antagonist, can eradicate gastric neuroendocrine tumours in patients with autoimmune chronic atrophic gastritis.
Boyce M; Moore AR; Sagatun L; Parsons BN; Varro A; Campbell F; Fossmark R; Waldum HL; Pritchard DM
Br J Clin Pharmacol; 2017 Mar; 83(3):466-475. PubMed ID: 27704617
[TBL] [Abstract][Full Text] [Related]
15. Two Types of Gastric Cancer Caused by the Same Underlying Condition.
Rustgi N; Shroff SG; Katona BW
Gastroenterology; 2018 Apr; 154(5):1246-1248. PubMed ID: 29410354
[No Abstract] [Full Text] [Related]
16. Duodenal neuroendocrine neoplasms: a still poorly recognized clinical entity.
Rossi RE; Rausa E; Cavalcoli F; Conte D; Massironi S
Scand J Gastroenterol; 2018; 53(7):835-842. PubMed ID: 29726295
[TBL] [Abstract][Full Text] [Related]
17. Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.
Moore AR; Boyce M; Steele IA; Campbell F; Varro A; Pritchard DM
PLoS One; 2013; 8(10):e76462. PubMed ID: 24098507
[TBL] [Abstract][Full Text] [Related]
18. Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
Lipiński M; Rydzewska G; Foltyn W; Andrysiak-Mamos E; Bałdys-Waligórska A; Bednarczuk T; Blicharz-Dorniak J; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nowakowska-Duława E; Pilch-Kowalczyk J; Poczkaj K; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Strzelczyk J; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Kos-Kudła B
Endokrynol Pol; 2017; 68(2):138-153. PubMed ID: 28540972
[TBL] [Abstract][Full Text] [Related]
19. [Chronic autoimmune gastritis : a multidisciplinary management].
Valdes-Socin H; Leclercq P; Polus M; Rohmer V; Beckers A; Louis E
Rev Med Liege; 2019 Nov; 74(11):598-605. PubMed ID: 31729849
[TBL] [Abstract][Full Text] [Related]
20. Gastric gastrinoma and diffuse G cell hyperplasia associated with chronic atrophic gastritis. Endoscopic detection and removal.
Russo A; Buffa R; Grasso G; Giannone G; Sanfilippo G; Sessa F; Solcia E
Digestion; 1980; 20(6):416-9. PubMed ID: 6250933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
